Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar 1;7(3):201-206.
doi: 10.15171/ijhpm.2017.145.

BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management

Victor G Rodwin  1 , Guilhem Fabre  2 , Rafael F Ayoub  3
Affiliations
Editorial

BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management

Victor G Rodwin et al. Int J Health Policy Manag. .

Abstract

BRIC nations - Brazil, Russia, India, and China - represent 40% of the world's population, including a growing aging population and middle class with an increasing prevalence of chronic disease. Their healthcare systems increasingly rely on prescription drugs, but they differ from most other healthcare systems because healthcare expenditures in BRIC nations have exhibited the highest revenue growth rates for pharmaceutical multinational corporations (MNCs), Big Pharma. The response of BRIC nations to Big Pharma presents contrasting cases of how governments manage the tensions posed by rising public expectations and limited resources to satisfy them. Understanding these tensions represents an emerging area of research and an important challenge for all those who work in the field of health policy and management (HPAM).

Keywords: BRIC; Brazil; China; Health Systems; Healthcare; India; Pharma; Pharmerging; Population Health; Russia.

PubMed Disclaimer

References

    1. Jakovljevic MB, Milovanovic O. Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front Public Health. 2015;3:65. doi: 10.3389/fpubh.2015.00065. - DOI - PMC - PubMed
    1. Jakovljevic MM. Comparison of historical medical spending patterns among the BRICS and G7. J Med Econ. 2016;19(1):70–76. doi: 10.3111/13696998.2015.1093493. - DOI - PubMed
    1. IMS Health. Pharmerging markets – Picking a pathway to success. http://www.pharmatalents.es/Publicaciones/detalle/7/post&33/like&1. Accessed June 12, 2013.
    1. Hamdouch A, Depret MH. La Nouvelle Economie Industrielle de la Pharmacie. Paris: Elsevier; 2001. 54-56
    1. Tannoury M, Attieh Z. The influence of emerging markets on the pharmaceutical industry. Curr Ther Res Clin Exp. 2017;86:19–22. doi: 10.1016/j.curtheres.2017.04.005. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources